BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siegel D, Kepa JK, Ross D. NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells. PLoS One. 2012;7:e44861. [PMID: 22984577 DOI: 10.1371/journal.pone.0044861] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Belanova AA, Smirnov DS, Makarenko MS, Belousova MM, Mashkina EV, Aleksandrova AA, Soldatov AV, Zolotukhin PV. Individual expression features of GPX2, NQO1 and SQSTM1 transcript variants induced by hydrogen peroxide treatment in HeLa cells. Genet Mol Biol 2017;40:515-24. [PMID: 28558074 DOI: 10.1590/1678-4685-GMB-2016-0005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
2 Del Favero G, Woelflingseder L, Braun D, Puntscher H, Kütt M, Dellafiora L, Warth B, Pahlke G, Dall’asta C, Adam G, Marko D. Response of intestinal HT-29 cells to the trichothecene mycotoxin deoxynivalenol and its sulfated conjugates. Toxicology Letters 2018;295:424-37. [DOI: 10.1016/j.toxlet.2018.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
3 Østrup O, Olbricht G, Østrup E, Hyttel P, Collas P, Cabot R. RNA profiles of porcine embryos during genome activation reveal complex metabolic switch sensitive to in vitro conditions. PLoS One 2013;8:e61547. [PMID: 23637850 DOI: 10.1371/journal.pone.0061547] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
4 Langie SA, Koppen G, Desaulniers D, Al-Mulla F, Al-Temaimi R, Amedei A, Azqueta A, Bisson WH, Brown DG, Brunborg G. Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis. 2015;36 Suppl 1:S61-S88. [PMID: 26106144 DOI: 10.1093/carcin/bgv031] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 11.4] [Reference Citation Analysis]
5 Pan D, Luo F, Liu X, Liu W, Chen W, Liu F, Kuang Y, Jiang J. A novel two-photon fluorescent probe with a long Stokes shift and a high signal-to-background ratio for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living cells and tissues. Analyst 2017;142:2624-30. [DOI: 10.1039/c7an00575j] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Lee WS, Ham W, Kim J. Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases. Life (Basel) 2021;11:1301. [PMID: 34947831 DOI: 10.3390/life11121301] [Reference Citation Analysis]
7 Jiang ZN, Ahmed SMU, Wang QC, Shi HF, Tang XW. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival. World J Gastroenterol 2021; 27(22): 3085-3096 [PMID: 34168410 DOI: 10.3748/wjg.v27.i22.3085] [Reference Citation Analysis]
8 Cuff S, Lewis RD, Chinje E, Jaffar M, Knox R, Weeks I. An improved cell-permeable fluorogenic substrate as the basis for a highly sensitive test for NAD(P)H quinone oxidoreductase 1 (NQO1) in living cells. Free Radic Biol Med 2018;116:141-8. [PMID: 29325897 DOI: 10.1016/j.freeradbiomed.2018.01.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Zhang K, Chen D, Ma K, Wu X, Hao H, Jiang S. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer. J Med Chem 2018;61:6983-7003. [DOI: 10.1021/acs.jmedchem.8b00124] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 13.5] [Reference Citation Analysis]
10 Siegel D, Bersie S, Harris P, Di Francesco A, Armstrong M, Reisdorph N, Bernier M, de Cabo R, Fritz K, Ross D. A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation. Redox Biol 2021;39:101840. [PMID: 33360352 DOI: 10.1016/j.redox.2020.101840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Yilmaz A, Mohamed N, Patterson KA, Tang Y, Shilo K, Villalona-Calero MA, Davis ME, Zhou X, Frankel W, Otterson GA, Beall HD, Zhao W. Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations. Int J Environ Res Public Health 2014;11:9491-502. [PMID: 25222473 DOI: 10.3390/ijerph110909491] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
12 Ross D, Siegel D. The diverse functionality of NQO1 and its roles in redox control. Redox Biol 2021;41:101950. [PMID: 33774477 DOI: 10.1016/j.redox.2021.101950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
13 Pinto G, Alhaiek AA, Amadi S, Qattan AT, Crawford M, Radulovic M, Godovac-Zimmermann J. Systematic nucleo-cytoplasmic trafficking of proteins following exposure of MCF7 breast cancer cells to estradiol. J Proteome Res. 2014;13:1112-1127. [PMID: 24422525 DOI: 10.1021/pr4012359] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
14 Zhao XZ, Wu XH. A small compound spindlactone A sensitizes human endometrial cancer cells to TRAIL-induced apoptosis via the inhibition of NAD(P)H dehydrogenase quinone 1. Onco Targets Ther 2018;11:3609-17. [PMID: 29950865 DOI: 10.2147/OTT.S165723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Hayes AJ, Skouras C, Haugk B, Charnley RM. Keap1-Nrf2 signalling in pancreatic cancer. Int J Biochem Cell Biol 2015;65:288-99. [PMID: 26117456 DOI: 10.1016/j.biocel.2015.06.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
16 Park MT, Oh ET, Song MJ, Lee H, Choi EK, Park HJ. NQO1 prevents radiation-induced aneuploidy by interacting with Aurora-A. Carcinogenesis 2013;34:2470-85. [PMID: 23803694 DOI: 10.1093/carcin/bgt225] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
17 Thomas NO, Shay KP, Hagen TM. Age-related loss of mitochondrial glutathione exacerbates menadione-induced inhibition of Complex I. Redox Biol 2019;22:101155. [PMID: 30851669 DOI: 10.1016/j.redox.2019.101155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kang HJ, Song HY, Ahmed MA, Guo Y, Zhang M, Chen C, Cristofanilli M, Horiuchi D, Vassilopoulos A. NQO1 regulates mitotic progression and response to mitotic stress through modulating SIRT2 activity. Free Radic Biol Med 2018;126:358-71. [PMID: 30114477 DOI: 10.1016/j.freeradbiomed.2018.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 Ehrke E, Steinmeier J, Stapelfeldt K, Dringen R. The Menadione-Mediated WST1 Reduction by Cultured Astrocytes Depends on NQO1 Activity and Cytosolic Glucose Metabolism. Neurochem Res 2021;46:88-99. [PMID: 31902045 DOI: 10.1007/s11064-019-02930-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Siegel D, Dehn DD, Bokatzian SS, Quinn K, Backos DS, Di Francesco A, Bernier M, Reisdorph N, de Cabo R, Ross D. Redox modulation of NQO1. PLoS One 2018;13:e0190717. [PMID: 29298345 DOI: 10.1371/journal.pone.0190717] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
21 Kimura A, Kitajima M, Nishida K, Serada S, Fujimoto M, Naka T, Fujii-Kuriyama Y, Sakamato S, Ito T, Handa H, Tanaka T, Yoshimura A, Suzuki H. NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation. J Exp Med 2018;215:2197-209. [PMID: 29934320 DOI: 10.1084/jem.20172024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
22 Li M, Li S, Liu B, Gu MM, Zou S, Xiao BB, Yu L, Ding WQ, Zhou PK, Zhou J, Shang ZF. PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients. J Exp Clin Cancer Res 2017;36:39. [PMID: 28259183 DOI: 10.1186/s13046-017-0508-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
23 Lee YH, Sun Y, Glickman RD. Ursolic Acid-Regulated Energy Metabolism-Reliever or Propeller of Ultraviolet-Induced Oxidative Stress and DNA Damage? Proteomes 2014;2:399-425. [PMID: 28250388 DOI: 10.3390/proteomes2030399] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Fagerholm R, Sprott K, Heikkinen T, Bartkova J, Heikkilä P, Aittomäki K, Bartek J, Weaver D, Blomqvist C, Nevanlinna H. Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer. Annals of Oncology 2013;24:2780-5. [DOI: 10.1093/annonc/mdt290] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
25 Ji M, Jin A, Sun J, Cui X, Yang Y, Chen L, Lin Z. Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. Oncol Lett. 2017;13:2996-3002. [PMID: 28521407 DOI: 10.3892/ol.2017.5821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
26 Meredith EL, Kumar A, Konno A, Szular J, Alsford S, Seifert K, Horn D, Wilkinson SR. Distinct activation mechanisms trigger the trypanocidal activity of DNA damaging prodrugs. Mol Microbiol 2017;106:207-22. [PMID: 28792090 DOI: 10.1111/mmi.13767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]